Quilliot D.
- Country
- France
- Department
- Endocrinologie, Diabétologie et de Nutrition
Research Overview
- Evaluation of BP1.4979 in Female Patients with Moderate to Severe Binge Eating Disorder: A Double-Blind, Placebo-Controlled Pilot Study
- Evaluation of Long-term Safety and Tolerability of Apraglutide in Patients with Short Bowel Syndrome-Intestinal Failure
- Evaluation of Choline Chloride Injection Versus Placebo in Adolescents and Adults with Intestinal Failure on Long-Term Parenteral Support
Data & Insights
Has run more than one trial at 11 of 50 partner sites.
Specializations
Metabolic and Nutritional Disorders
The investigator’s work emphasizes the pathophysiology and treatment of Diabetes, Obesity, and metabolic liver disease such as Non‑alcoholic Steatohepatitis (NASH) and metabolic dysfunction‑associated steatohepatitis (MASH).
- Type 2 diabetes management
- Weight‑related cardiovascular risk
- Fibrosis progression in NASH/MASH
- Metabolic syndrome interventions
Research integrates endocrine, nutritional, and hepatologic expertise to improve metabolic health outcomes.
Cardiovascular and Renal Disease
Focus is placed on acute and chronic conditions of the heart and kidneys, including Acute Coronary Syndrome, Myocardial Infarction, Heart Failure, Hypertension, and Chronic Kidney Disease.
- Secondary prevention after myocardial infarction
- Therapeutic strategies for heart failure with preserved ejection fraction
- Renal outcome optimization in diabetic nephropathy
- Blood‑pressure control in high‑risk cardiovascular cohorts
Clinical investigations aim to reduce major adverse cardiovascular events and preserve renal function.
Oncology and Hematologic Malignancies
Extensive involvement in solid and hematologic cancers, covering Colorectal Cancer, Hepatocellular Carcinoma, Non‑Small Cell Lung Cancer, Acute Myeloid Leukemia, and Lymphoma.
- Targeted therapy for metastatic colorectal disease
- Immunotherapy combinations in liver cancer
- FLT3‑mutated AML treatment pathways
- Novel agents for B‑cell lymphomas
Research seeks to improve survival and disease‑free intervals across diverse tumor types.
Autoimmune and Inflammatory Disorders
Key interests include systemic immune conditions such as Systemic Lupus Erythematosus, Rheumatoid Arthritis, Inflammatory Bowel Disease (Crohn’s disease and ulcerative colitis), and ANCA‑associated Vasculitis.
- Biologic therapies for refractory lupus nephritis
- JAK‑inhibitor efficacy in rheumatoid arthritis
- Maintenance strategies for ulcerative colitis remission
- Vasculitis management in organ‑preserving protocols
Efforts target disease control while minimizing long‑term organ damage.
Neurological and Neurodegenerative Disorders
Investigator contributions extend to neuro‑cognitive and neuro‑degenerative diseases, notably Alzheimer Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Parkinson’s Disease.
- Biomarker‑driven trials in early Alzheimer’s disease
- Relapse‑prevention therapies for multiple sclerosis
- Neuroprotective approaches in ALS
- Symptom‑targeted interventions for Parkinsonian motor decline
Studies aim to modify disease trajectories and enhance quality of life for affected patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.